Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · Cancer Discovery · 44 citations
https://doi.org/10.1158/2159-8290.cd-23-0216
M
Matheus Henrique Dias
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
985
Citations
15
h-index
17
i10-index
Matheus Henrique Dias is an academic researcher from The Netherlands Cancer Institute. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Cancer, Hypoxia, and Metabolism & Cancer Treatment and Pharmacology. The author has an h-index of 15, co-authored 59 publications.
ORCID: 0000-0002-2961-1142Papers by this author
worksConserved Gene Microsynteny Unveils Functional Interaction Between Protein Disulfide Isomerase and Rho Guanine-Dissociation Inhibitor Families
2017 · Scientific Reports · 32 citations
https://doi.org/10.1038/s41598-017-16947-5
The phosphatase inhibitor LB-100 creates neoantigens in colon cancer cells through perturbation of mRNA splicing
2024 · EMBO Reports · 17 citations
https://doi.org/10.1038/s44319-024-00128-3
The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy
2024 · Cancer Cell · 11 citations
https://doi.org/10.1016/j.ccell.2024.04.014
Table S3 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26134828.v1
Table S7 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26134816.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat